Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.

Background: Key challenges of biopsy-based determination of prostate cancer aggressiveness include tumour heterogeneity, biopsy-sampling error, and variations in biopsy interpretation. The resulting uncertainty in risk assessment leads to significant overtreatment, with associated costs and morbidit...

Descripción completa

Detalles Bibliográficos

Publicado en:	British Journal of Cancer Vol. 111; no. 6; pp. 1201 - 1213
Autores principales:	Shipitsin, M, Small, C, Choudhury, S, Giladi, E, Friedlander, S, Nardone, J, Hussain, S, Hurley, A D, Ernst, C, Huang, Y E, Chang, H, Nifong, T P, Rimm, D L, Dunyak, J, Loda, M, Berman, D M, Blume-Jensen, P
Formato:	research Journal Article
Publicado:	Springer Nature 9/9/2014
Acceso en línea:	Ver este registro en EBSCOhost